PIMA542095
Crotedumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542095-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542095 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Crotedumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
REGN-1193
Immunogen
Human GCGR
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
2.55 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG4 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Crotedumab has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Compare Similar Items
Show Difference
Antigen: Crotedumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: REGN-1193
Immunogen: Human GCGR
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.55 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Crotedumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
REGN-1193
Immunogen:
Human GCGR
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.55 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Rivabazumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BA1126; PcrV
Immunogen: Pseudomonas aeruginosa (Gram negative bacteria) PcrV
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.11 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein L
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 F(ab') κ
Antigen:
Rivabazumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BA1126; PcrV
Immunogen:
Pseudomonas aeruginosa (Gram negative bacteria) PcrV
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.11 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein L
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 F(ab') κ
Antigen: Navicixizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: OMP-305B83
Immunogen: Human DLL4/VEGFA
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Navicixizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
OMP-305B83
Immunogen:
Human DLL4/VEGFA
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Prezalumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AMG 557; MEDI-5872
Immunogen: Human ICOSLG/B7-H2/B7RP-1/CD275
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.51 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Prezalumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AMG 557; MEDI-5872
Immunogen:
Human ICOSLG/B7-H2/B7RP-1/CD275
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.51 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ